Prescribing Pattern of Antimicrobial Agents in Pelvic Inflammatory Disease - A Hospital Based Prospective Study
DOI:
https://doi.org/10.21276/fh1atm28Keywords:
Pelvic Inflammatory diseases, Antimicrobial agent, Drug utilization studies.Abstract
Pelvic inflammatory diseases (PID) is a noteworthy wellbeing concern prompting significant gynecological grimness among ladies in conceptive age gathering. Along these lines this review was attempted to dissect the medicine example of Antimicrobial Agents in patients experiencing Pelvic Inflammatory Diseases. Methods: A cross-sectional study was conducted at the Department of Gynecology & Obstetrics of World College of Medical Science and Research, Jhajjar, Haryana; for a period of 5 months during December 2016 to April 2017. A total of 210 prescriptions of clinically diagnosed PID cases from Outpatient Department (OPD) and Inpatient Department (IPD) were collected and analyzed in the department of Pharmacology based on Drug utilization WHO indicators. Results: Average number of AMAs per prescription was 2.26. Majority of patients prescribed were Antifungals (n=112, P=23.57%) followed by Fluoroquinolones (n=102, P=21.47%), Aminoglycosides (19.36%), Nitroimidazoles (16.0 %) and Doxycyclines (P=15.78%). Urinary antiseptics were the least prescribed class (3.78%). Individually, most commonly used agents of these is Clotrimazole + Tinidazole followed by Doxycycline and least prescribed was Nitrofurantoin. Conclusions: There was minimal difference between defined recommendations in standard treatment guidelines and the clinical use of antimicrobial agents. The only lacking part of this study was lesser use of generic drugs.
Downloads
References
Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility- A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-92.
Aggarwal D. Reproductive tract infections - challenges and responses; Health for the Millions 2001;3:21-3.
Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. British Journal of Obstetrics & Gynaecology 1995; 102:407- 14.
Recommendations arising from the 31st Study Group: The Prevention of Pelvic infection. in Templeton A, ed. The prevention of pelvic, pp 267-70. London: RCOG Press, 1996.
Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765-6.
Goldman DA, Weinstein RA, Wenzel RP. Strategies to prevent and control the emergence of antimicrobial resistant micro-organisms in hospital. JAMA. 1996;275:234-49.
Lesar TS, Briceland LL. Survey of antibiotic control policies in university-affiliated teaching institutions. Ann Pharmacother. 1996;30:31-34.
Sharma S, Goel M, Sharma R. Drug utilization study in pelvic inflammatory disease in a teaching hospital in North India. International Journal of Pharmaceutical Research and Bio-science, 2013;2(4):152-167.
Basu J, Bhowmick S, Pal A et. al. Prescribing pattern of antimicrobial agents in pelvic inflammatory disease at a rural teaching hospital in India. Int J Health Sci Res. 2015; 5(8):316-323.
Saini S, Gupta N, Aparna, Batra G, Arora D R. Role of anaerobes in acute pelvic inflammatory disease. Indian J Med Microbiol, 2003;21:18992
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
